Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

889 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Analysis of Clinical Phenotypes through Machine Learning of First-Line H. pylori Treatment in Europe during the Period 2013-2022: Data from the European Registry on H. pylori Management (Hp-EuReg).
Nyssen OP, Pratesi P, Spínola MA, Jonaitis L, Pérez-Aísa Á, Vaira D, Saracino IM, Pavoni M, Fiorini G, Tepes B, Bordin DS, Voynovan I, Lanas Á, Martínez-Domínguez SJ, Alfaro E, Bujanda L, Pabón-Carrasco M, Hernández L, Gasbarrini A, Kupcinskas J, Lerang F, Smith SM, Gridnyev O, Leja M, Rokkas T, Marcos-Pinto R, Meštrović A, Marlicz W, Milivojevic V, Simsek H, Kunovsky L, Papp V, Phull PS, Venerito M, Boyanova L, Boltin D, Niv Y, Matysiak-Budnik T, Doulberis M, Dobru D, Lamy V, Capelle LG, Nikolovska Trpchevska E, Moreira L, Cano-Català A, Parra P, Mégraud F, O'Morain C, Ortega GJ, Gisbert JP, On Behalf Of The Hp-EuReg Investigators. Nyssen OP, et al. Among authors: gisbert jp. Antibiotics (Basel). 2023 Sep 10;12(9):1427. doi: 10.3390/antibiotics12091427. Antibiotics (Basel). 2023. PMID: 37760723 Free PMC article.
The prevalence of peptic ulcer not related to Helicobacter pylori or non-steroidal anti-inflammatory drug use is negligible in southern Europe.
Arroyo MT, Forne M, de Argila CM, Feu F, Arenas J, de la Vega J, Garrigues V, Mora F, Castro M, Bujanda L, Cosme A, Castiella A, Gisbert JP, Hervas A, Lanas A. Arroyo MT, et al. Among authors: gisbert jp. Helicobacter. 2004 Jun;9(3):249-54. doi: 10.1111/j.1083-4389.2004.00219.x. Helicobacter. 2004. PMID: 15165261
Third-line rescue therapy with levofloxacin after two H. pylori treatment failures.
Gisbert JP, Castro-Fernández M, Bermejo F, Pérez-Aisa A, Ducons J, Fernández-Bermejo M, Bory F, Cosme A, Benito LM, López-Rivas L, Lamas E, Pabón M, Olivares D; H. pylori Study Group of the Asociación Española de Gastroenterología. Gisbert JP, et al. Am J Gastroenterol. 2006 Feb;101(2):243-7. doi: 10.1111/j.1572-0241.2006.00457.x. Am J Gastroenterol. 2006. PMID: 16454825 Clinical Trial.
Second-line rescue therapy with levofloxacin after H. pylori treatment failure: a Spanish multicenter study of 300 patients.
Gisbert JP, Bermejo F, Castro-Fernández M, Pérez-Aisa A, Fernández-Bermejo M, Tomas A, Barrio J, Bory F, Almela P, Sánchez-Pobre P, Cosme A, Ortiz V, Niño P, Khorrami S, Benito LM, Carneros JA, Lamas E, Modolell I, Franco A, Ortuño J, Rodrigo L, García-Durán F, O'Callaghan E, Ponce J, Valer MP, Calvet X; H. pylori Study Group of the Asociación Española de Gastroenterología. Gisbert JP, et al. Am J Gastroenterol. 2008 Jan;103(1):71-6. doi: 10.1111/j.1572-0241.2007.01500.x. Epub 2007 Aug 31. Am J Gastroenterol. 2008. PMID: 17764498 Clinical Trial.
Treatment of Helicobacter pylori infection.
O'Connor A, Gisbert J, O'Morain C. O'Connor A, et al. Helicobacter. 2009 Sep;14 Suppl 1:46-51. doi: 10.1111/j.1523-5378.2009.00704.x. Helicobacter. 2009. PMID: 19712168 Review.
889 results